Alcon forecast sales of between $10.2 and $10.4 billion for 2025, after the eye care group reported higher fourth-quarter revenue underpinned by its surgical division on Tuesday.
16d
PopCrush on MSNStop Using This Nasal Wash Right Now! FDA Recall Due to Possible ‘Serious or Fatal’ SymptomsThis company has announced a voluntary recall after its nasal wash product tested positive for a dangerous bacteria.
"There have been no reports of adverse events related to this recall," Alcon Laboratories said in a statement about its Systane eye drops The company Alcon Laboratories, maker of a popular brand ...
2d
MyChesCo on MSNMadrigal Pharmaceuticals Announces Changes to Board of DirectorsCONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced the appointment of Jacqualyn (“Jackie”) Fouse, ...
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments ...
Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are impressive. Yet, a challenging international market with geopolitical ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
RBC Capital analyst Jack Reynolds-Clark reiterated a Buy rating on Alcon (ALC – Research Report) yesterday and set a price target of ...
Reports Q4 revenue $2.48B, consensus $2.47B. “In 2024, our unwavering focus on innovation and operational excellence delivered another set of ...
In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the ...
The webcast can be accessed online through Alcon's Investor Relations website, i.e. investor.alcon.com. Listeners should log on approximately 10 minutes in advance. A replay will be available ...
Alcon, in partnership with TrueVision 3D Surgical, has launched NGENUITY 3D, a complete digital solution for vitreoretinal surgery that uses an ultra-fast high-definition digital camera to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results